Key facts
- Octagon Capital Advisors is a hedge fund based in New York, New York with 7 tracked portfolio companies.
- Notable positions include AbogenBio, Bluejay Therapeutics, Alebund Pharmaceuticals.
- The team roster lists 2 people.
- Octagon Capital Advisors reports $985.3M in regulatory assets under management across 4 private funds, per its SEC Form ADV (2026-03).
About Octagon Capital Advisors
182856-52P
Registered with the SEC
Form ADV · 2026-03 · CRD 306424- Regulatory AUM
- $985.3M
- Private fund assets
- $1.2B
- Private funds
- 4 · 3 private equity, 1 hedge
- Staff
- 10
- Registered office
- NEW YORK, NY
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as OCTAGON CAPITAL ADVISORS LP).
Free account
See more of the book
- ·The top 10 names in the book — of 7 recorded positions
- ·Watchlist + alerts for Octagon Capital Advisors's activity
Create free account
No card required
Portfolio
7 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| AbogenBio | — | ▮ | ▮ | ▮ |
| Bluejay Therapeutics | Drug Discovery | ▮ | ▮ | ▮ |
| Alebund Pharmaceuticals | — | ▮ | ▮ | ▮ |
+ 4 more companies · all 7, priced and dated or a free account shows the top 10 names — no card | ||||
Team
2 people on record — 2 with verified contacts
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked
- What companies does Octagon Capital Advisors invest in?
- Octagon Capital Advisors has 7 recorded portfolio companies, including AbogenBio, Bluejay Therapeutics, Alebund Pharmaceuticals.
- What is Octagon Capital Advisors's AUM?
- Octagon Capital Advisors manages approximately $985.3M in assets.